Semicon industry told to invest in nanotechnology

Though India had become a dominant player in the global software arena, it is a laggard in the electronics hardware industry despite resources and talent, says founder director-general of National Informatics Centre N. Seshagiri

News |

BANGALORE, INDIA: The fledgling Indian semiconductor industry has to invest in the research and development (R&D) of nanotechnology to face the challenge of disruptive technologies and shrinking innovative product cycles, a top expert said on Monday.

"Nanotechnology is the future of the electronics industry worldwide. With disruptive technologies and product cycles shrinking, the Indian semicon industry has to invest in nanotechnology R&D to innovate applications using nano materials and nano tubes," founder director-general of National Informatics Centre N. Seshagiri said here.

Delivering the inaugural address at the sixth Vision Summit of the Indian Semiconductor Association (ISA) here, Seshagiri told about 300 delegates that though India had become a dominant player in the global software arena with about $60 billion export revenue, it is a laggard in the electronics hardware industry despite resources and talent.

"It will be a blunder to ignore the innovations taking place in nanotechnology worldwide, especially in the US, Germany and Korea and application of nano materials and nano tubes in the manufacturing of electronics products for diverse applications, especially consumer goods, including mobiles, laptops and tablets, medical equipment, energy efficiency and security," the former special secretary to the IT department and Planning Commission said.

Noting that the sunrise nanotechnology sector was a $20 billion industry worldwide with about 1,000 nano-based products rolled out by 400 firms across 25 countries, the eminent technocrat said the market size for nanotech electronics was estimated to be $1.6 trillion over the next two years.

"The absence of a chip-making (fab) facility and sound electronics manufacturing base should not deter the Indian semicon and hardware industry from using nanotechnology in developing sub-systems and electronic devices, which will account for about 30 percent of the projected $30 billion industry in 2014," Seshagiri pointed out.

Referring to the huge investments being made by global chip maker Intel and IT major IBM in developing 40 nanometre and sub-25 nanometre flash memory, the former official said the cost of producing nano materials and nano tubes had to be reduced substantially through R&D and innovation so as to bring down the overall cost of end-products.

"Presently, it costs about $400,000 to produce a kilogram of nano tubes even in the US. As nanotechnology and miniaturisation of electronic products are going to be order of this decade, the Indian electronics hardware industry had to catch up with the rest of the world to be in race for a pie of the multi-billion dollar market," Seshagiri asserted.

Read more:

Semicon industry told to invest in nanotechnology

Research on Women of Color: Interdisciplinary Medicine and Health, Part Two – Video


Research on Women of Color: Interdisciplinary Medicine and Health, Part Two
Moderator -- Professor Ruth Enid Zambrana, University of Maryland. Panel -- Professor Angela Rose Black, University of Illinois at Urbana-Champaign and Profe...

By: University of Illinois at Urbana-Champaign

Follow this link:

Research on Women of Color: Interdisciplinary Medicine and Health, Part Two - Video

Research on Women of Color: Interdisciplinary Medicine and Health, Part One – Video


Research on Women of Color: Interdisciplinary Medicine and Health, Part One
Moderator -- Professor Ruth Enid Zambrana, University of Maryland. Panel -- Professor Angela Rose Black, University of Illinois at Urbana-Champaign and Profe...

By: University of Illinois at Urbana-Champaign

Continue reading here:

Research on Women of Color: Interdisciplinary Medicine and Health, Part One - Video

Penn Medicine Experts Available for Comment on Latest Research at SLEEP 2013

PHILADELPHIA - Perelman School of Medicine at the University of Pennsylvania clinicians and researchers will be presenting compelling data and giving talks about emerging issues in the field of sleep medicine during SLEEP 2013, in Baltimore, MD, June 2 5, 2013.

In addition to their own presentations, Penn experts are available for interviews and outside comment in the following areas:

Obstructive Sleep Apnea

Allan Pack, MBChB, PhD Chief, Division of Sleep Medicine and Director, Center for Sleep and Respiratory Neurobiology

Dr. Packs clinical expertise is in sleep disorders with a particular focus on diagnosis and management of obstructive sleep apnea. His research focuses on the genetics/genomics of sleep and its disorders. His laboratory is conducting studies in Drosophila and mice and translating these findings to humans. A particular focus of Dr. Packs work is to evaluate the genetic determinants of sleep homeostasis.

Chronobiology and Sleep Loss/Deprivation

David F. Dinges, PhD - Professor and Chief, Division of Sleep and Chronobiology in the Department of Psychiatry

Dr. Dinges laboratory is dedicated to scientific discovery of the physiological, cognitive and functional changes resulting from sleep loss and behavioral stressors in humans, and to evaluating behavioral, pharmacological and technological countermeasures to these effects. His research has involved extensive laboratory, simulator and field studies on the consequences of sleep loss and circadian misalignment from both lifestyle and medical disorders; effects of sleep disorders; recovery potential of naps; nature of sleep inertia; impact of cumulative sleep debt; differential vulnerability to the neurobehavioral effects of sleep loss; and development of technologies for monitoring human neurobehavioral capability.

Sleep and General Health

Michael Grandner, PhD Instructor, Department of Psychiatry and Member, Behavioral Sleep Medicine Program

Go here to see the original:

Penn Medicine Experts Available for Comment on Latest Research at SLEEP 2013

Annual Conference to Address Key Operational and Business Concerns of Genomic Medicine

KEENE, N.H.--(BUSINESS WIRE)--

G2 Intelligence a 30+ year leader in research, reporting, and analysis on the business of the diagnostic lab industry today announced the final agenda for MDx NEXT, with dynamic sessions, case studies, and interactive panel discussions surrounding the theme: Gaining Ground in Molecular Testing and Genomic Medicine. G2s annual event will be held in a new city at a new venue this year: the Westin Las Vegas Hotel Casino & Spa, June 12-14, 2013.

Everyone with a stake in molecular diagnostics can look forward to expert insight and advice on how clinical laboratories of all sizes are successfully using molecular testing, despite the challenging regulatory and ever-changing business environments, said Stephanie Murg, G2s Managing Director and conference program chair. In fact, with genomic medicine firmly established and growing rapidly, the time is ideal for labs to find out how they can actively harness the evolving markets clinical utility, latest technology, and novel business models to grow. This years conference is dedicated to that purpose.

Industry professionals who want to know where the market is headed wont want to miss this years conference, continues Kimberly Scott, G2s Managing Editor and program co-chair. The agenda is oriented toward a broad range of labs, and will also tackle such hot-button topics as reimbursement, building a more cost-effective test menu, and the prospects for next-generation sequencing.

Confirmed sessions to include:

Attendees are encouraged to make the most of their experience with one or both pre-conference workshops on Wednesday, June 12:

MDx NEXT keynote speakers are:

Distinguished faculty in attendance to include:

To find out more, or to register for G2s MDx NEXT conference, go to http://www.MDxConference.com, call 1-800-531-1026, or email customerservice@G2Intelligence.com.

Group discounts are available for 3 or more people from the same organization. For group registrations, please call Jeff Watkins at 973-718-4709 to facilitate your registration, or email jwatkins@G2Intelligence.com.

More here:

Annual Conference to Address Key Operational and Business Concerns of Genomic Medicine

UC Riverside Medical School Official Craig Byus Receives Lifetime Achievement Award

David Geffen School of Medicine at UCLA awards Lifetime Achievement in Medical Education award to long-time medical education leader at UC Riverside

By Kris Lovekin on May 28, 2013

Craig V. Byus, (right) senior associate dean, academic affairs for the UCR School of Medicine accepts the award from Alan G. Robinson, associate vice chancellor and senior associate dean for the David Geffen School of Medicine

By Jessica Kump

RIVERSIDE, Calif. (www.ucr.edu) Craig V. Byus, Ph.D., senior associate dean of academic affairs and research in the UC Riverside School of Medicine, received the Lifetime Achievement in Medical Education Award from the David Geffen School of Medicine at UCLA on May 22.

Dr. Alan Robinson, associate vice chancellor and senior associate dean at the David Geffen School of Medicine at UCLA, presented the award to Byus at the UCR School of Medicines annual clinical faculty recognition and student awards ceremony in downtown Riverside.

His leadership and role modeling at Riverside was instrumental in developing the program here, said Robinson, who emphasized Byus role in leading the development of the unique mission of the UCR/UCLA Thomas Haider Program in Biomedical Sciences.

Byus is only the third recipient of the Lifetime Achievement Award in its 18-year existence. In addition to his exemplary career in teaching and service, the award recognizes his leadership in the complete redesign of the UCR/UCLA Thomas Haider Program in Biomedical Sciences, which resulted in a program geared toward diversifying the physician workforce and training physicians who would serve the underserved populations within Inland Southern California.

This is a much-deserved honor that I am pleased to see Craig receive, said Dr. G. Richard Olds, dean of the UCR School of Medicine. I strongly believe that had it not been for his vision, commitment and wise counsel in the transformation of the UCR/UCLA Thomas Haider Program in Biomedical Sciences, the UCR School of Medicine would not be where it is today.

The original UCR/UCLA program, established in 1974, enrolled 250 UCR freshmen in a seven-year program that led to an M.D. The program, by design, pared each cohort of 250 students down to 24 students by the third undergraduate year, which was the first year of medical school.

Follow this link:

UC Riverside Medical School Official Craig Byus Receives Lifetime Achievement Award

Plasticized Bodies Come to Singapore Medical School

At a Singapore medical school, doctors-to-be are learning anatomy on human bodies preserved in plastic.

The bodies, which were donated to science, have undergone a process called plastination, which replaces the fat and water in a cadaver with plastic and other polymers. The treatment maintains the tissues' structural properties and prevents decay.

The medical school at Nanyang Technological University (NTU) will be using plastinated bodies in its first class in August. The school has ordered two whole bodies from Germany, as well as body parts, including hearts, lungs, brains, limbs and torsos.

Plastinated specimens have several advantages: They are of good quality, sturdy and preserve intricate details of the muscles, arteries, veins and nerves. These structures start to deteriorate in traditional cadavers.

"These highly detailed, plastinated human specimens are very durable, and can be repeatedly handled by students without deterioration, and it can be stored just like any inert object," anatomy professor Dinesh Kumar Srinivasan of NTU's medical school said in a statement.

The plastinated bodies and body parts will replace traditionally embalmed cadavers, which are in short supply in Singapore, where people may fear that their body will be mishandled after death.

The downside to using plastinated bodies is that students lose the hands-on experience of dissecting a human body themselves, which many medical educators consider a vital part of a physician's training. But given the shortage of body donors in Singapore, the use of plastinated bodies in medical schools may become more common. Warwick University in the United Kingdom and several other medical schools are also using plastinated specimens.

Plastination was first developed by German anatomist Gunther von Hagens in 1977. Hagens created the popular but controversial traveling exhibition of plastinated bodies called "Body Worlds."

Follow Tanya Lewis on Twitterand Google+.Follow us @livescience, Facebook& Google+. Original article onLiveScience.com.

See more here:

Plasticized Bodies Come to Singapore Medical School